Beuter C, Volkers G, Radic T, Goldberg J, van den Anker J. Efficacy and safety of multiple doses of tapentadol oral solution in the treatment of moderate to severe acute pain in children aged 2 to <18 years - a randomized, double-blind, placebo-controlled trial. J Pain Res 2019;12:3099–112. https://www.ncbi.nlm.nih.gov/pubmed/32009813
Groenewald CB, Zhou C, Palermo TM, Van , Cleve WC. Associations between opioid prescribing patterns and overdose among privately insured adolescents. Pediatrics 2019;144(5). https://www.ncbi.nlm.nih.gov/pubmed/31575622
Kaabachi O, el Jaouani H, Safi H, Jelel C, Ben Ghachem M. [Comparative study of two tramadol prescription protocols for postoperative analgesia in children]. Tunis Med 2002;80(11):685–90. https://www.ncbi.nlm.nih.gov/pubmed/12664518
Schnabel A, Reichl SU, Meyer-Friessem C, Zahn PK, Pogatzki-Zahn E. Tramadol for postoperative pain treatment in children. Cochrane Database Syst Rev 2015;(3):CD009574. https://www.ncbi.nlm.nih.gov/pubmed/25785365
Schnabel A, Reichl SU, Zahn PK, Pogatzki-Zahn E. Nalbuphine for postoperative pain treatment in children. Cochrane Database Syst Rev 2014;(7):CD009583. https://www.ncbi.nlm.nih.gov/pubmed/25079857
Society for Paediatric Anaesthesia in New Zealand and Australia (SPANZA) review group members. SPANZA advisory on tramadol - May 2017: recommendations following FDA warnings about tramadol use in children. Morisset, New South Wales: SPANZA; May 2017. https://www.spanza.org.au/news/spanza-advisory-on-tramadol-may-2017/
Stollenwerk A, Sohns M, Heisig F, Elling C, von Zabern D. Review of post-marketing safety data on tapentadol, a centrally acting analgesic. Adv Ther 2018;35(1):12–30. https://www.ncbi.nlm.nih.gov/pubmed/29270779
Tsutaoka BT, Ho RY, Fung SM, Kearney TE. Comparative toxicity of tapentadol and tramadol utilizing data reported to the National Poison Data System. Ann Pharmacother 2015;49(12):1311–6. https://www.ncbi.nlm.nih.gov/pubmed/26369569
